Blackstone’s Recursion Pharmaceuticals RXRX Stock Holding History
Bought
Maintained
Sold
Other funds holding RXRX
Blackstone's RXRX Position: Q3 2026 in Review
Blackstone opened a new position in Recursion Pharmaceuticals (RXRX) in Q3 2026: 17,020 shares worth $70.3K. The stake represents ﹤0.01% of the portfolio and ranks #400 among its holdings.
354 funds tracked by Wall St. Rank hold RXRX as of Q3 2026.
- Blackstone held 17,020 shares of Recursion Pharmaceuticals worth $70.3K as of Q3 2026.
- Recursion Pharmaceuticals was a new Blackstone position in Q3 2026.
- Recursion Pharmaceuticals made up ﹤0.01% of Blackstone's portfolio in Q3 2026, its #400 holding.
- 354 funds tracked by Wall St. Rank held Recursion Pharmaceuticals as of Q3 2026.
Based on Blackstone's 13F filing for Q3 2026, filed 16 Nov 2026.